Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy.

Savannah V Wooten, Fei Wang,Michael E Roth, Guanshu Liu,J Andrew Livingston,Behrang Amini,Susan C Gilchrist,Michelle Hildebrandt,Eugenie S Kleinerman

Cancer medicine（2023）

引用 0|浏览10

暂无评分

摘要

Significant skeletal muscle loss is experienced early during treatment in AYA cancer patients. Reductions in skeletal muscle blood flow may be a key contributing factor to anthracycline doxorubicin induced skeletal muscle loss.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要